Education
About Us
Working with TipRanks
Follow Us
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
Total Valuation
CAMP4 Therapeutics Corporation has a market cap or net worth of $309.21M. The enterprise value is -$8.43M.
Market Cap$309.21M
Enterprise Value-$8.43M
Share Statistics
CAMP4 Therapeutics Corporation has 51,881,134 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding51,881,134
Owned by Insiders31.11%
Owned by Institutions42.26%
Financial Efficiency
CAMP4 Therapeutics Corporation’s return on equity (ROE) is -0.82 and return on invested capital (ROIC) is -73.94%.
Return on Equity (ROE)-0.82
Return on Assets (ROA)-0.66
Return on Invested Capital (ROIC)-73.94%
Return on Capital Employed (ROCE)-0.77
Revenue Per Employee11.85K
Profits Per Employee-941.65K
Employee Count55
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CAMP4 Therapeutics Corporation is ―. CAMP4 Therapeutics Corporation’s PEG ratio is 0.06.
PE Ratio―
PS Ratio156.16
PB Ratio1.61
Price to Fair Value1.61
Price to FCF-2.21
Price to Operating Cash Flow-2.92
PEG Ratio0.06
Income Statement
In the last 12 months, CAMP4 Therapeutics Corporation had revenue of 652.00K and earned -51.79M in profits. Earnings per share was -2.66.
Revenue652.00K
Gross Profit652.00K
Operating Income-53.09M
Pretax Income-51.79M
Net Income-51.79M
EBITDA-51.39M
Earnings Per Share (EPS)-2.66
Cash Flow
In the last 12 months, operating cash flow was -47.13M and capital expenditures -542.00K, giving a free cash flow of -47.68M billion.
Operating Cash Flow-47.13M
Free Cash Flow-47.68M
Free Cash Flow per Share-0.92
Dividends & Yields
CAMP4 Therapeutics Corporation pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.94
52-Week Price Change10.17%
50-Day Moving Average4.34
200-Day Moving Average2.81
Relative Strength Index (RSI)60.57
Average Volume (3m)1.59M
Important Dates
CAMP4 Therapeutics Corporation upcoming earnings date is Mar 26, 2026, After Close (Confirmed).
Last Earnings DateNov 20, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
CAMP4 Therapeutics Corporation as a current ratio of 6.92, with Debt / Equity ratio of 10.82%
Current Ratio6.92
Quick Ratio6.92
Debt to Market Cap0.00
Net Debt to EBITDA1.08
Interest Coverage Ratio0.00
Taxes
In the past 12 months, CAMP4 Therapeutics Corporation has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CAMP4 Therapeutics Corporation EV to EBITDA ratio is -0.90, with an EV/FCF ratio of -1.01.
EV to Sales71.21
EV to EBITDA-0.90
EV to Free Cash Flow-1.01
EV to Operating Cash Flow-1.02
Balance Sheet
CAMP4 Therapeutics Corporation has $75.25M in cash and marketable securities with $6.35M in debt, giving a net cash position of $68.91M billion.
Cash & Marketable Securities$75.25M
Total Debt$6.35M
Net Cash$68.91M
Net Cash Per Share$1.33
Tangible Book Value Per Share$3.24
Margins
Gross margin is 89.06%, with operating margin of -8142.33%, and net profit margin of -7943.40%.
Gross Margin89.06%
Operating Margin-8142.33%
Pretax Margin-7943.40%
Net Profit Margin-7943.40%
EBITDA Margin-7882.21%
EBIT Margin-8142.33%
Analyst Forecast
The average price target for CAMP4 Therapeutics Corporation is $9.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$9.00
Price Target Upside51.01% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast―
EPS Growth Forecast5.51%